Periscope Capital’s Longevity Health Holdings, Inc. Warrant XAGEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-195,990
Closed -$32.4K 363
2024
Q1
$32.4K Sell
195,990
-44,278
-18% -$7.49K 0.01% 255
2023
Q4
$55K Sell
240,268
-2,600
-1% -$445 0.01% 241
2023
Q3
$58.7K Sell
242,868
-272,732
-53% -$67.4K 0.01% 355
2023
Q2
$103K Hold
515,600
0.01% 355
2023
Q1
$84K Hold
515,600
﹤0.01% 471
2022
Q4
$78.9K Buy
515,600
+66,500
+15% +$11.6K ﹤0.01% 522
2022
Q3
$134K Buy
449,100
+324,400
+260% +$103K ﹤0.01% 605
2022
Q2
$48K Hold
124,700
﹤0.01% 704
2022
Q1
$97K Buy
+124,700
New +$94.6K ﹤0.01% 766

Other funds holding XAGEW

Periscope Capital's XAGEW Position: Q2 2024 in Review

Periscope Capital sold out of Longevity Health Holdings, Inc. Warrant (XAGEW) in Q2 2024, closing a stake of 195,990 shares — an estimated $32.4K sold.

Periscope Capital first reported a position in XAGEW in Q1 2022 and held it in 9 quarters. The position peaked at $134K in Q3 2022. 16 funds tracked by Wall St. Rank hold XAGEW as of Q2 2024.

  • Periscope Capital reported no remaining Longevity Health Holdings, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
  • Periscope Capital sold 195,990 Longevity Health Holdings, Inc. Warrant shares in Q2 2024, an estimated $32.4K.
  • Periscope Capital first reported a position in Longevity Health Holdings, Inc. Warrant in Q1 2022 and held it in 9 quarters.
  • Periscope Capital's Longevity Health Holdings, Inc. Warrant position peaked at $134K in Q3 2022.
  • 16 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Warrant as of Q2 2024.

Based on Periscope Capital's 13F filing for Q2 2024, filed 13 Aug 2024.